{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:20:59Z","timestamp":1790799659339,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Bioprojet","award":["No Number"],"award-info":[{"award-number":["No Number"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s40261-021-01104-8","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T17:21:25Z","timestamp":1638465685000},"page":"65-74","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy of Pitolisant 20 mg in Reducing Excessive Daytime Sleepiness and Fatigue in Patients with Obstructive Sleep Apnoea Syndrome: An Individual Patient Data Meta-analysis"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3272-2353","authenticated-orcid":false,"given":"Philippe","family":"Lehert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"key":"1104_CR1","doi-asserted-by":"publisher","unstructured":"Peppard PE et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177(9):1006\u201314. https:\/\/doi.org\/10.1093\/aje\/kws342.","DOI":"10.1093\/aje\/kws342"},{"issue":"7","key":"1104_CR2","first-page":"967","volume":"31","author":"PM Macey","year":"2008","unstructured":"Macey PM, Kumar R, Woo MA, Valladares EM, Yan-Go FL, Harper RM. Brain structural changes in obstructive sleep apnea. Sleep. 2008;31(7):967\u201377.","journal-title":"Sleep."},{"key":"1104_CR3","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1001\/jama.283.14.1829","volume":"283","author":"F Nieto","year":"2000","unstructured":"Nieto F, Young T, Lind B, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA. 2000;283:1829\u201336. https:\/\/doi.org\/10.1001\/jama.283.14.1829.","journal-title":"JAMA"},{"key":"1104_CR4","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1056\/NEJM200005113421901","volume":"342","author":"P Peppard","year":"2000","unstructured":"Peppard P, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378\u201384. https:\/\/doi.org\/10.1056\/NEJM200005113421901.","journal-title":"N Engl J Med"},{"issue":"5","key":"1104_CR5","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S2213-2600(15)00090-9","volume":"3","author":"I Rosenzweig","year":"2015","unstructured":"Rosenzweig I, Glasser M, Polsek D, et al. Sleep apnoea and the brain: a complex relationship. Lancet Respir Med. 2015;3(5):404\u201314. https:\/\/doi.org\/10.1016\/S2213-2600(15)00090-9.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"1104_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40463-016-0156-0","volume":"45","author":"BW Rotenberg","year":"2016","unstructured":"Rotenberg BW, Murariu D, Pang KP. Trends in CPAP adherence over twenty years of data collection: a flattened curve. J Otolaryngol Head Neck Surg. 2016;45(1):43. https:\/\/doi.org\/10.1186\/s40463-016-0156-0.","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"2","key":"1104_CR7","doi-asserted-by":"publisher","first-page":"2001272","DOI":"10.1183\/13993003.01272-2020","volume":"57","author":"MR Bonsignore","year":"2021","unstructured":"Bonsignore MR, Randerath W, Schiza S, et al. European Respiratory Society statement on sleep apnoea, sleepiness and driving risk. Eur Respir J. 2021;57(2):2001272. https:\/\/doi.org\/10.1183\/13993003.01272-2020.","journal-title":"Eur Respir J"},{"issue":"3","key":"1104_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000222811","volume":"78","author":"D Rodenstein","year":"2009","unstructured":"Rodenstein D. Sleep apnea: traffic and occupational accidents\u2014individual risks, socioeconomic and legal implications. Respiration. 2009;78(3):241\u20138. https:\/\/doi.org\/10.1159\/000222811.","journal-title":"Respiration"},{"issue":"6","key":"1104_CR9","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1378\/chest.124.6.2192","volume":"124","author":"JRL Schwartz","year":"2003","unstructured":"Schwartz JRL, Hirshkowitz M, Erman EK, et al. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study. Chest. 2003;124(6):2192\u20139. https:\/\/doi.org\/10.1378\/chest.124.6.2192.","journal-title":"Chest"},{"issue":"4","key":"1104_CR10","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/j.1476-5381.2011.01286.x","volume":"163","author":"J-C Schwartz","year":"2011","unstructured":"Schwartz J-C. The histamine H3 receptor: from discovery to clinical trials with pitolisant. Br J Pharmacol. 2011;163(4):713\u201321. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01286.x.","journal-title":"Br J Pharmacol"},{"key":"1104_CR11","unstructured":"European Medicines Agency: Committee for Medicinal Products for Human Use (CHMP). Assessment report, Wakix. International non-proprietary name: pitolisant. Procedure no. EMEA\/H\/C\/002616\/0000. 2015. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Public_assessment_report\/human\/002616\/WC500204749.pdf. Accessed 13 Apr 2021."},{"key":"1104_CR12","unstructured":"US Food and Drug Administration (FDA). WAKIX\u00ae (pitolisant) tablets, for oral use. Highlights of prescribing information. 2019. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/211150s000lbl.pdf. Accessed 13 Apr 2021."},{"issue":"2","key":"1104_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s40263-020-00703-x","volume":"34","author":"YN Lamb","year":"2020","unstructured":"Lamb YN. Pitolisant in narcolepsy with or without cataplexy. CNS Drugs. 2020;34(2):207\u201318. https:\/\/doi.org\/10.1007\/s40263-020-00703-x.","journal-title":"CNS Drugs"},{"issue":"23","key":"1104_CR14","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1016\/0024-3205(95)02206-x","volume":"57","author":"S Miyazaki","year":"1995","unstructured":"Miyazaki S, Imaizumi M, Onodera K. Effects of thioperamide, a histamine H3-receptor antagonist, on a scopolamine-induced learning deficit using an elevated plus-maze test in mice. Life Sci. 1995;57(23):2137\u201344. https:\/\/doi.org\/10.1016\/0024-3205(95)02206-x.","journal-title":"Life Sci"},{"issue":"3","key":"1104_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0091-3057(95)00248-u","volume":"50","author":"K Meguro","year":"1995","unstructured":"Meguro K, Yanai K, Sakai N, et al. Effects of thioperamide, a histamine H3 antagonist, on the step-through passive avoidance response and histidine decarboxylase activity in senescence-accelerated mice. Pharmacol Biochem Behav. 1995;50(3):321\u20135. https:\/\/doi.org\/10.1016\/0091-3057(95)00248-u.","journal-title":"Pharmacol Biochem Behav"},{"issue":"5","key":"1104_CR16","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/pl00005200","volume":"357","author":"K Onodera","year":"1998","unstructured":"Onodera K, Miyazaki S, Imaizumi M, et al. Improvement by FUB 181, a novel histamine H3-receptor antagonist, of learning and memory in the elevated plus-maze test in mice. Naunyn Schmiedebergs Arch Pharmacol. 1998;357(5):508\u201313. https:\/\/doi.org\/10.1007\/pl00005200.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"20","key":"1104_CR17","doi-asserted-by":"publisher","first-page":"35105","DOI":"10.1016\/j.chest.2020.09.281","volume":"S0012\u20133692","author":"JL P\u00e9pin","year":"2020","unstructured":"P\u00e9pin JL, Georgiev O, Tiholov R, et al. Pitolisant for residual excessive daytime sleepiness in OSA patients adhering to CPAP: a randomized trial. Chest. 2020;S0012\u20133692(20):35105\u20139. https:\/\/doi.org\/10.1016\/j.chest.2020.09.281.","journal-title":"Chest"},{"issue":"9","key":"1104_CR18","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1164\/rccm.201907-1284OC","volume":"201","author":"Y Dauvilliers","year":"2020","unstructured":"Dauvilliers Y, Verbraecken J, Partinen M, et al. Pitolisant for daytime sleepiness in patients with obstructive sleep apnea who refuse continuous positive airway pressure treatment. A randomized trial. Am J Respir Crit Care Med. 2020;201(9):1135\u201345. https:\/\/doi.org\/10.1164\/rccm.201907-1284OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"15","key":"1104_CR19","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1111\/bph.15067","volume":"177","author":"P Rusjan","year":"2020","unstructured":"Rusjan P, Sabioni P, Di Ciano P, Mansouri E, Boileau I, Laveill\u00e9 A, Capet M, Duvauchelle T, Schwartz JC, Robert P, Le Foll B. Exploring occupancy of the histamine H3\u00a0receptor by pitolisant in humans using PET. Br J Pharmacol. 2020;177(15):3464\u201372. https:\/\/doi.org\/10.1111\/bph.15067.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"1104_CR20","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540\u20135. https:\/\/doi.org\/10.1093\/sleep\/14.6.540.","journal-title":"Sleep"},{"key":"1104_CR21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1046\/j.1365-2869.1997.00039.x","volume":"6","author":"LS Bennett","year":"1997","unstructured":"Bennett LS, Stradling JR, Davies JO. A behavioral test to assess daytime sleepiness in obstructive sleep apnoea. J Sleep Res. 1997;6:142\u20135. https:\/\/doi.org\/10.1046\/j.1365-2869.1997.00039.x.","journal-title":"J Sleep Res"},{"issue":"6","key":"1104_CR22","first-page":"862","volume":"142","author":"P Pichot","year":"1984","unstructured":"Pichot P, Brun JP. Brief self-evaluation questionnaire for depressive, asthenic and anxious dimensions. Ann Med Psychol (Paris). 1984;142(6):862\u20135.","journal-title":"Ann Med Psychol (Paris)."},{"key":"1104_CR23","unstructured":"Higgins JPT, Altman DG, Sterne JAC. Chapter 8: assessing risk of bias in included studies. In: Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. http:\/\/handbook.cochrane.org."},{"key":"1104_CR24","unstructured":"European Medicines Agency: Committee for Medicinal Products for Human Use (CHMP). Assessment report, Wakix. International non-proprietary name: pitolisant. Procedure No. EMEA\/H\/C\/002616\/0000. 2015. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Public_assessment_report\/human\/002616\/WC500204749.pdf. Accessed 13 Apr 2019."},{"key":"1104_CR25","doi-asserted-by":"publisher","first-page":"105522","DOI":"10.1016\/j.phrs.2021.105522","volume":"167","author":"J Wang","year":"2021","unstructured":"Wang J, Li X, Yang S, Wang T, Xu Z, Xu J, Gao H, Chen G. Pitolisant versus placebo for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: A meta-analysis from randomized controlled trials. Pharmacol Res. 2021;167:105522. https:\/\/doi.org\/10.1016\/j.phrs.2021.105522.","journal-title":"Pharmacol Res."},{"issue":"4","key":"1104_CR26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.026.","journal-title":"J Clin Epidemiol"},{"key":"1104_CR27","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2307\/2531158","volume":"40","author":"PC O\u2019Brien","year":"1984","unstructured":"O\u2019Brien PC. Procedures for comparing samples with multiple endpoints. Biometrics. 1984;40:1079\u201387.","journal-title":"Biometrics"},{"key":"1104_CR28","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. New York: Academic Press; 1988.","edition":"2"},{"issue":"12","key":"1104_CR29","doi-asserted-by":"publisher","first-page":"zsy185","DOI":"10.1093\/sleep\/zsy185","volume":"41","author":"P Lehert","year":"2018","unstructured":"Lehert P, Falissard B. Multiple treatment comparison in narcolepsy: a network meta-analysis. Sleep. 2018;41(12):zsy185. https:\/\/doi.org\/10.1093\/sleep\/zsy185.","journal-title":"Sleep"},{"issue":"15","key":"1104_CR30","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1002\/sim.918","volume":"20","author":"JP Higgins","year":"2001","unstructured":"Higgins JP, Whitehead A, Turner RM, et al. Meta-analysis of continuous outcome data from individual patients. Stat Med. 2001;20(15):2219\u201341. https:\/\/doi.org\/10.1002\/sim.918.","journal-title":"Stat Med"},{"key":"1104_CR31","doi-asserted-by":"publisher","unstructured":"Pinheiro JC, Bates DM. Linear mixed-effects models: basic concepts and examples. In: Mixed-effects models in S and S-PLUS. Statistics and computing. Springer, New York; 2000. pp. 3\u201356. https:\/\/doi.org\/10.1007\/0-387-22747-4_1.","DOI":"10.1007\/0-387-22747-4_1"},{"issue":"6","key":"1104_CR32","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/sim.650","volume":"20","author":"SE Brockwell","year":"2001","unstructured":"Brockwell SE, Gordon IR. A comparison of statistical methods for meta-analysis. Stat Med. 2001;20(6):825\u201340. https:\/\/doi.org\/10.1002\/sim.650.","journal-title":"Stat Med"},{"key":"1104_CR33","unstructured":"US Food and Drug Administration. Multiple endpoints in clinical trials guidance for industry. US Department of Health and Human Services, 2017. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/multiple-endpoints-clinical-trials-guidance-industry. Accessed 20 Apr 2021."},{"key":"1104_CR34","unstructured":"Ozawade. EMA. 2021. https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/ozawade-epar-public-assessment-report_en.pdf. Accessed 30 Nov 2021."},{"issue":"Suppl 1","key":"1104_CR35","doi-asserted-by":"publisher","first-page":"e186","DOI":"10.1016\/j.sleep.2017.11.544","volume":"40","author":"P Lehert","year":"2017","unstructured":"Lehert P. Epworth sleepiness scale ESS: determination of a minimum clinically relevant difference. Sleep Med. 2017;40(Suppl 1):e186\u20137. https:\/\/doi.org\/10.1016\/j.sleep.2017.11.544.","journal-title":"Sleep Med"},{"issue":"7","key":"1104_CR36","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1164\/rccm.201704-0672LE","volume":"197","author":"S Patel","year":"2018","unstructured":"Patel S, Kon SSC, Nolan CM, et al. The Epworth sleepiness scale: minimum clinically important difference in obstructive sleep apnea. Am J Respir Crit Care Med. 2018;197(7):961\u20133. https:\/\/doi.org\/10.1164\/rccm.201704-0672LE.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"1104_CR37","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1136\/thoraxjnl-2018-211959","volume":"74","author":"S Crook","year":"2019","unstructured":"Crook S, Sievi NA, Bloch KE, et al. Minimum important difference of the Epworth Sleepiness Scale in obstructive sleep apnoea: estimation from three randomized controlled trials. Thorax. 2019;74(4):390\u20136. https:\/\/doi.org\/10.1136\/thoraxjnl-2018-211959.","journal-title":"Thorax"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-021-01104-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-021-01104-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-021-01104-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T11:18:54Z","timestamp":1641986334000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-021-01104-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1104"],"URL":"https:\/\/doi.org\/10.1007\/s40261-021-01104-8","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,2]]},"assertion":[{"value":"7 November 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data and detailed results of the analyses that support the findings of this study are available in the supplementary material to this article. Any further detail on the used material, including the data, methods, statistical analysis plan, can be obtained by a simple request to the author.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability Statement"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This article was supported by Bioprojet. Bioprojet, No Number. Philippe LEHERT.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"P. Lehert is the only author, contributed to the conception, design, acquisition of data, analysis and interpretation of data; participated in drafting, reviewing and revising the manuscript and approved its submission.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contribution statement"}},{"value":"P. Lehert received an unconditional grant from Bioprojet for conducting this analysis.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics approval is not applicable to this article since it is a meta-analysis.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}